10x Genomics to Report Second Quarter Financial Results on August 11, 2020
July 08 2020 - 5:43PM
10x Genomics (Nasdaq: TXG) today announced it will report financial
results for the second quarter 2020 after market close on Tuesday,
August 11, 2020. The company’s management will webcast a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time to discuss its results, business
developments and outlook.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.10xgenomics.com. The webcast
will be archived and available for replay for at least 45 days
after the event.
About 10x Genomics10x Genomics is a life
science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world including 97 of the
top 100 global research institutions and 19 of the top 20 global
pharmaceutical companies, and have been cited in over 1,000
research papers on discoveries ranging from oncology to immunology
and neuroscience. The company's patent portfolio comprises more
than 740 issued patents and patent applications.
Disclosure Information10x Genomics uses filings
with the Securities and Exchange Commission, its website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and its social media accounts as means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD.
ContactsMedia:media@10xgenomics.comInvestors:investors@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Apr 2023 to Apr 2024